Publications by authors named "V Drug"
Article Synopsis
- Novel direct oral anticoagulants (DOACs) like apixaban are widely used to treat non-valvular atrial fibrillation, but have been linked to adverse reactions such as esophagitis dissecans superficialis (EDS).
- A case study of a 73-year-old woman revealed that after several weeks on apixaban, she experienced weakness, difficulty swallowing, and gastrointestinal bleeding, leading to a diagnosis of EDS.
- The patient was treated with a proton pump inhibitor and iron supplements, and after recovery, opted for rivaroxaban instead of the initially suggested vitamin K antagonist for her anticoagulation therapy.
The Montreal consensus recognizes chronic cough as an extra-esophageal manifestation of gastroesophageal reflux disease. We performed a meta-analysis to assess the effects of acid-suppressive medications in adults with non-specific chronic cough. The protocol was registered on PROSPERO (CRD42022368769).
View Article and Find Full Text PDFInflammatory bowel disease (IBD) comprises two types of chronic intestinal disorders: Crohn's disease and ulcerative colitis. In long-standing ulcerative colitis disease activity, histological persistent inflammation has been linked to an increased risk of relapse, and long-term corticosteroid use, even when endoscopic remission is reached. In Crohn's disease, the discontinuous nature of lesions and transmural inflammation have limited the standardized histological assessment.
View Article and Find Full Text PDFIrritable bowel syndrome (IBS) has a global prevalence of around 4.1% and is associated with a low quality of life and increased healthcare costs. Current guidelines recommend that IBS is diagnosed using the symptom-based Rome IV criteria.
View Article and Find Full Text PDFUnlabelled: Patients undergoing ablation for atrial fibrillation may be at increased risk of developing gastroesophageal reflux disease. We prospectively studied the presence of symptomatic gastroesophageal reflux disease in naïve patients who underwent atrial fibrillation ablation.
Methods: The presence of typical symptoms suggestive of gastroesophageal reflux disease was clinically assessed by the gastroenterologist at baseline and at 3 months after ablation.